Skip to main content
Royal Sense Limited logo

Royal Sense Limited — Investor Relations & Filings

Ticker · 544143 ISIN · INE0QQG01019 LEI · 6488G7BH3X6KM57M2983 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 7 across all filing types
Latest filing 2026-05-25 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 544143

About Royal Sense Limited

https://www.royalsense.in/

Royal Sense Limited specializes in the distribution and supply of a comprehensive range of medical equipment, surgical instruments, and laboratory consumables. The company provides essential healthcare products, including diagnostic kits, medical disposables, laboratory reagents, and specialized surgical tools. Serving a diverse clientele that includes hospitals, diagnostic centers, and various healthcare institutions, the firm focuses on maintaining a robust supply chain to ensure the availability of high-quality medical supplies. Its operations emphasize quality assurance and the integration of advanced medical technologies to support clinical diagnostics and patient care. By leveraging a broad network of manufacturers and suppliers, the company facilitates the procurement of critical healthcare infrastructure and consumables required for modern medical practices.

Recent filings

Filing Released Lang Actions
Please find enclosed herewith the Financial Results for the year ended 31st March, 2026.
Interim / Quarterly Report Classification · 75% confidence The document is a formal disclosure under SEBI Listing Regulations of the Board meeting outcome, including the actual audited standalone and consolidated financial results (with full financial statements and auditor’s report) for the half-year and year ended March 31, 2026. It is not a marketing presentation (IP), dividend notice (DIV), governance report (CGR), or full annual report (10-K). Nor is it merely a highlights‐only earnings release (ER) or a short notice announcing a report’s publication (RPA). Because it contains substantive financial statements and audit opinions for a period shorter than a full fiscal year (the half-year results) and also the annual numbers, it most closely matches the Interim / Quarterly Report category (IR). FY 2026
2026-05-25 English
Please find enclosed herewith the Outcome of Board Meeting of the Company dated 25th May, 2026.
Audit Report / Information Classification · 82% confidence The document is a Regulation 30 disclosure of the Board Meeting outcomes that primarily includes the Audited Standalone and Consolidated Financial Results and the Independent Auditor’s Report for the half‐year and full year ended 31 March 2026. It contains the auditor’s opinion, basis, responsibilities, and the actual financial statements. This is not merely an announcement (RPA) nor a full annual report (10-K). It is a standalone audit report and audited results, fitting the Audit Report / Information category (AR).
2026-05-25 English
Please find enclosed herewith the submissions regarding the non-applicability of the submission of Annual Secretarial Compliance Report under Regulation 24A(2) of SEBI (Listing Obligations ....
Regulatory Filings Classification · 92% confidence The document is a letter filed with the stock exchange under SEBI Listing Obligations disclosing non-applicability of the Annual Secretarial Compliance Report for the financial year ending March 31, 2026. It is not the report itself but a regulatory compliance announcement. It does not contain financial statements, voting results, or executive changes, but is a general regulatory filing under LODR. Therefore, it falls under Regulatory Filings (RNS).
2026-05-22 English
Royal Sense Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1) Consider and approve the Audited ....
Regulatory Filings Classification · 82% confidence The document is a formal intimation under SEBI Listing Regulations informing the stock exchange of a scheduled Board meeting date to consider financial results and other matters. It does not itself contain financial statements or management changes, nor is it the actual financial report. It is a regulatory announcement/filing under Reg. 29 of SEBI LODR and thus falls under the general Regulatory Filings category (RNS).
2026-05-20 English
Please find enclosed herewith the submission regarding the launch of the latest products by the Company.
Regulatory Filings Classification · 85% confidence The document is a formal disclosure to BSE under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the launch of new pharmaceutical products. It is not a financial report, earnings release, management change, or dividend notice, but rather a regulatory exchange filing detailing corporate developments. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-05-20 English
Please find enclosed herewith the submission regarding the appointment of the Company Secretary and Compliance Officer of the Company.
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to the stock exchange (BSE Limited) regarding the outcome of a Board of Directors meeting held on 19th May 2026. The key content is the appointment of a new Company Secretary and Compliance Officer, including detailed personal and professional information about the appointee. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in the board or senior management. The document is short (3494 characters) and focuses solely on management change without financial data or broader management discussion. Therefore, it fits the category of Board/Management Information (MANG).
2026-05-19 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.